The Analytical Scientist Power List returns to celebrate the successes of the field’s leading lights!
12/13/2013 | Christian Huber, Barry Karger, John Yates
Proteomics is all the rage. Here, three leaders in the field – Christian Huber, Barry Karger and John Yates – go beyond the hype to discuss where the field is going and what might hold progress back
12/13/2013 | Dev Kant Shandilya
How I grew an active LinkedIn group of over 7,500 members with a single aspiration – to make all our jobs easier.
12/13/2013 | Joshua M. Pearce
Open-source scientific hardware is a reality. It gives researchers more freedom to experiment with design and can open new doors in research. What’s stopping you?
12/13/2013 | Adrian Stevens
What the 2013 Nobel Prize in Chemistry says about predictive sciences
12/13/2013 | André Deelder
Where does clinical bio-molecular mass spectrometry (MS) sit on the steep slope between hype and hope?
12/12/2013 | Rich Whitworth
A business consultancy report estimates that the global mass spectrometry market will reach $2.5 billion by 2017
What is it, why is it, and where on earth is it? The 2013 TASIAs have the answer.
11/20/2013 | Sponsored by Metrohm
Metrohm's customizable system copes with the tough requirements of the radiopharmaceutical industry and pharmacopoeial regulations.
11/19/2013 | Sponsored by VWR
UV detection methods are the most widely used in HPLC owing to the seemingly ubiquitous presence of chromophores in analytes.
11/19/2013 | Richard Gallagher
Sitting Down with Sue Lunte, Ralph N. Adams Institute for Bioanalytical Chemistry, Departments of Chemistry and Pharmaceutical Chemistry, University of Kansas, USA.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
On an IM-MS Crusade
Lighting Up Archaeological Science
The Winner Takes It All